4D Molecular Therapeutics, Inc. - Common Stock (NQ:FDMT)

11.90 -0.88 (-6.89%)

Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 4D Molecular Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

4DMT Completes Enrollment of Phase 2 PRISM Clinical Trial for Intravitreal 4D-150 in Patients with Wet AMD and Reports Interim Safety and Tolerability Data

July 17, 2023

From 4D Molecular Therapeutics, Inc.

Via GlobeNewswire

4D Molecular Poised For Success: FDA Discussion And Solid Position In Competitive Genetic Medicine Space, Says Analyst ↗

July 05, 2023

Chardan Research analyst Geulah Livshits initiated coverage on 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) with a Buy rating and

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2023 ↗

July 05, 2023

Via Benzinga

Analyst Ratings for 4D Molecular Therapeutics ↗

July 05, 2023

Via Benzinga

Analyst Ratings for 4D Molecular Therapeutics ↗

June 08, 2023

Via Benzinga

4D Molecular Therapeutics Stock Is Trading Higher Today - Here's Why ↗

June 08, 2023

4D Molecular Therapeutics (NASDAQ: FDMT) announced interim data from the 4D-710 Phase 1/2 AEROW trial for

Via Benzinga

Why Oxford Industries Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 08, 2023

Gainers Baosheng Media Group Holdings Limited (NASDAQ: BAOS) shares climbed 91.2% to $10.81.

Via Benzinga

Carvana, Designer Brands, REV Group And Other Big Stocks Moving Higher On Thursday ↗

June 08, 2023

U.S. stocks traded higher, with the Nasdaq Composite rising around 70 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 08, 2023

Via Benzinga

The Latest Analyst Ratings for 4D Molecular Therapeutics ↗

April 13, 2023

Via Benzinga

SVB Securities Maintains Market Perform Rating for 4D Molecular Therapeutics: Here's What You Need To Know ↗

April 13, 2023

Via Benzinga

Why Semtech Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket ↗

June 08, 2023

Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares rose 50.5% to $0.20 in pre-market trading after dropping 5% on Wednesday.

Via Benzinga

4DMT Presents Positive Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial in Patients with Cystic Fibrosis at the ECFS 46th Annual Meeting

June 07, 2023

From 4D Molecular Therapeutics, Inc.

Via GlobeNewswire

4D Molecular Therapeutics to Participate in Upcoming Investor Conferences

June 01, 2023

From 4D Molecular Therapeutics, Inc.

Via GlobeNewswire

4DMT to Present Interim Data from 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis Lung Disease at the European Cystic Fibrosis Society (ECFS) 46th Annual Meeting

May 24, 2023

From 4D Molecular Therapeutics, Inc.

Via GlobeNewswire

$50M Bet On Coinbase Global? Check Out These 4 Stocks Insiders Are Buying ↗

May 12, 2023

Although US stocks closed mixed on Thursday, there were a few notable insider trades.

Via Benzinga

4DMT Announces Presentation on Aerosolized 4D-710 for Treatment of Cystic Fibrosis at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting

May 11, 2023

From 4D Molecular Therapeutics, Inc.

Via GlobeNewswire

4D Molecular Therapeutics Reports First Quarter 2023 Financial Results and Operational Highlights

May 10, 2023

From 4D Molecular Therapeutics, Inc.

Via GlobeNewswire

4D Molecular Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

May 09, 2023

Underwriters’ full exercise of option brings gross proceeds to $138.0 million

From 4D Molecular Therapeutics, Inc.

Via GlobeNewswire

4D Molecular Therapeutics to Participate in Upcoming Investor Conferences

May 08, 2023

From 4D Molecular Therapeutics, Inc.

Via GlobeNewswire

4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

May 04, 2023

From 4D Molecular Therapeutics, Inc.

Via GlobeNewswire

4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock

May 04, 2023

From 4D Molecular Therapeutics, Inc.

Via GlobeNewswire

What's Going On With 4D Molecular Therapeutics Stock Today ↗

April 27, 2023

4D Molecular Therapeutics (NASDAQ: FDMT) shares are trading lower after the company released interim clinical data from the Phase 1 Dose Exploration stage of the 4D-150 Phase 1/2 PRISM trial for wet...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 27, 2023

Via Benzinga

Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 27, 2023

Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its...

Via Benzinga

Dow Surges 100 Points; Meta Platforms Reports Upbeat Results ↗

April 27, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining around 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.38% to 33,429.66 while the NASDAQ rose 0.88%...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 27, 2023

Via Benzinga

4DMT Presents Positive Interim Data from Intravitreal 4D-150 Phase 1/2 PRISM Clinical Trial in Patients with Wet AMD at ARVO 2023

April 27, 2023

From 4D Molecular Therapeutics, Inc.

Via GlobeNewswire

4DMT Acquires Complement Pathway Inhibitor Payload for 4D-175 Product Candidate for Geographic Atrophy

April 24, 2023

From 4D Molecular Therapeutics, Inc.

Via GlobeNewswire

4DMT to Present Interim Data from 4D-150 Phase 1/2 PRISM Clinical Trial for Wet AMD at ARVO 2023, and Promotes Robert Kim, M.D. to Chief Medical Officer

April 13, 2023

From 4D Molecular Therapeutics, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.